Dodge & Cox Global Stock Fund
Dodge & Cox Funds · Series S000022057 · 2 share classes
data updated 2026-08-10
Fund profile
As filed in the prospectus · 2026 Q2
The Fund seeks long-term growth of principal and income.
The fund invests in a diversified global portfolio of medium-to-large companies selected for appearing undervalued relative to their long-term profit growth prospects, with at least 40% of assets in non-U.S. securities and at least 80% in equities. The manager evaluates companies on valuation, financial strength, earnings and cash flow potential, competitive position, management quality, and material environmental, social, and governance factors, alongside the political and economic stability of their home countries. Because security selection depends on the manager's assessment of undervaluation and growth outlook, fund returns will diverge from any benchmark index.
| Share class | Gross | Net |
|---|---|---|
| DODWX | 0.62% | 0.62% |
| DOXWX | 0.57% | 0.52% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 26.00% · as of 2026 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q1
| Stocks | 98.05% |
| Cash & short-term | 1.73% |
| Derivatives | 0.11% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: SUNB, Roche Holding AG, Reckitt Benckiser Group PLC, ROP, London Stock Exchange Group PLC, Novo Nordisk A/S, DSM-Firmenich AG, VSNT
Largest exited: Ashtead Group PLC, Sanofi SA, Roche Holding AG, Reckitt Benckiser Group PLC, Canadian Treasury Bill, IEX, IndusInd Bank, Ltd.
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Feb 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| — | — | — | — | — | |
| — | — | — | — | — |
Mar 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Value | Shares |
|---|---|---|---|---|
| — | Taiwan Semiconductor Manufacturing Co., Ltd. | 4.06% | $487.24M | 8.6M |
| GOOG | Alphabet, Inc.GOOG | 3.40% | $408.68M | 1.4M |
| RTX | RTX Corp.RTX | 3.15% | $378.76M | 2.0M |
| SCHW | The Charles Schwab Corp.SCHW | 2.63% | $315.76M | 3.4M |
| GLAXF | GSK PLCGLAXF | 2.55% | $305.79M | 11.2M |
| — | Bayer AG | 1.88% | $226.04M | 5.0M |
| REGN | Regeneron Pharmaceuticals, Inc.REGN | 1.81% | $217.54M | 281.6K |
| BKNG | Booking Holdings, Inc.BKNG | 1.78% | $213.88M | 50.8K |
| MSFT | Microsoft Corp.MSFT | 1.78% | $213.29M | 576.2K |
| AAIGF | AIA Group, Ltd.AAIGF | 1.73% | $207.46M | 18.5M |
Top 10 positions are 24.78% of net assets, top 25 47.36%, across 97 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free